Morimoto, T.; Nakazawa, T.; Matsuda, R.; Nishimura, F.; Nakamura, M.; Yamada, S.; Nakagawa, I.; Park, Y.-S.; Tsujimura, T.; Nakase, H.
CRISPR-Cas9–Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells. Int. J. Mol. Sci. 2021, 22, 3489.
https://doi.org/10.3390/ijms22073489
AMA Style
Morimoto T, Nakazawa T, Matsuda R, Nishimura F, Nakamura M, Yamada S, Nakagawa I, Park Y-S, Tsujimura T, Nakase H.
CRISPR-Cas9–Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells. International Journal of Molecular Sciences. 2021; 22(7):3489.
https://doi.org/10.3390/ijms22073489
Chicago/Turabian Style
Morimoto, Takayuki, Tsutomu Nakazawa, Ryosuke Matsuda, Fumihiko Nishimura, Mitsutoshi Nakamura, Shuichi Yamada, Ichiro Nakagawa, Young-Soo Park, Takahiro Tsujimura, and Hiroyuki Nakase.
2021. "CRISPR-Cas9–Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells" International Journal of Molecular Sciences 22, no. 7: 3489.
https://doi.org/10.3390/ijms22073489
APA Style
Morimoto, T., Nakazawa, T., Matsuda, R., Nishimura, F., Nakamura, M., Yamada, S., Nakagawa, I., Park, Y.-S., Tsujimura, T., & Nakase, H.
(2021). CRISPR-Cas9–Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells. International Journal of Molecular Sciences, 22(7), 3489.
https://doi.org/10.3390/ijms22073489